Skip to main content
Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
8.87
+0.57 (6.87%)
At close: Apr 28, 2026, 4:00 PM EDT
8.91
+0.04 (0.45%)
After-hours: Apr 28, 2026, 6:46 PM EDT

ARCT Revenue

In the year 2025, Arcturus Therapeutics Holdings had annual revenue of $82.03M, down -46.14%. Arcturus Therapeutics Holdings had revenue of $7.20M in the quarter ending December 31, 2025, a decrease of -68.39%.

Revenue (ttm)
$82.03M
Revenue Growth
-46.14%
P/S Ratio
3.07
Revenue / Employee
$739,018
Employees
111
Market Cap
252.11M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202582.03M-70.28M-46.14%
Dec 31, 2024152.31M-14.49M-8.69%
Dec 31, 2023166.80M-39.20M-19.03%
Dec 31, 2022206.00M193.64M1,566.79%
Dec 31, 202112.36M2.82M29.56%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Heron Therapeutics 154.90M
Codexis 70.39M
Fennec Pharmaceuticals 44.64M
Voyager Therapeutics 40.37M
Orchestra BioMed Holdings 33.48M
Adagene 7.67M
Camp4 Therapeutics 3.50M
Milestone Pharmaceuticals 1.55M
Revenue Rankings

ARCT News

More News